Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)

SHE:300122 Revenue

Chongqing Zhifei Biological Products had revenue of 2.15B CNY in the quarter ending March 31, 2026, a decrease of -8.64%. This brings the company's revenue in the last twelve months to 8.75B, down -48.52% year-over-year. In the year 2025, Chongqing Zhifei Biological Products had annual revenue of 8.96B, down -65.61%.

• Revenue (ttm): 8.75B
• Revenue Growth: -48.52%
• P/S Ratio: 3.72
• Revenue / Employee: 1.39M
• Employees: 6,292
• Market Cap: 32.53B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.96B	-17.09B	-65.61%
Dec 31, 2024	26.05B	-26.87B	-50.77%
Dec 31, 2023	52.92B	14.65B	38.30%
Jan 1, 2023	38.26B	7.61B	24.83%
Dec 31, 2021	30.65B	15.46B	101.79%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error